SUBSCRIBE

Breaking News on Supplements & Nutrition - EuropeUS edition

Products > Clinical Study

Lynside® Pro GI+, an efficient and fast-acting probiotic solution

Published: 26-May-2014 | Format: PDF file | Document type: Clinical Study
Lesaffre

Provide to 10-20% of the population who’s affected by IBS and intestinal pain a safe solution.
Discover our 3 studies that have demonstrated the efficiency of our fast-acting probiotic.

Lesaffre is a main actor in the field of yeasts in the world. Based on its 160 years of experience in biotechnology, we identified and patented a specific yeast strain which is particularly efficient to target intestinal pain and discomfort : Lynside® Pro GI+.

Supplier's Info Centre

Logo Lesaffre

Fill Form to Download Now!

*
*
*
*
*
*
*
*

Please note that any information that you supply is protected by our Privacy and Cookie Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.